结合晶体学和结合亲和力数据,形成一个小分子重叠的新型数据集
Sophia M N Hönig1,2, Torben Gutermuth2, Christiane Ehrt2
1BioSolveIT, An der Ziegelei 79, 53757, Sankt Augustin, Germany.
Journal of computer-aided molecular design
|December 4, 2024
概括
一个新的数据集,LOBSTER,解决了在药物发现中评估小分子叠加方法的挑战. 本资源提供了一个标准化的基准,用于评估和优化用于识别潜在药物候选者的计算技术.
科学领域:
- 计算化学是一种计算化学.
- 结构生物学是结构生物学.
- 药物发现 药物发现
背景情况:
- 小分子叠加在药物发现中至关重要,但由于稀疏和过时的数据集,缺乏严格的性能评估.
- 现有的数据集往往是特定于应用程序,不可用或不独立于方法,阻碍了可靠的基准测试.
研究的目的:
- 介绍LOBSTER数据集,这是一个新的,公开可用的,方法独立的资源,用于基准测试和优化小分子叠加方法.
- 提供标准化数据集,以促进药物发现中的计算技术的严格评估.
主要方法:
- LOBSTER数据集是使用完全自动化的工作流程创建的,从蛋白质数据库 (PDB) 提取连接物,并应用连接物效率过器.
- 通过对齐相同的结合点来生成联结体组,并根据实验确定的结合方向和形状叠加联结体.
- 该数据集包括671个连接体组合 (3521种蛋白质中的3583个连接体) 和72,734个连接体对,按体积重叠分为10个子集,以提供不同的难度级别.
主要成果:
- 洛布斯特数据集包含具有高架构多样性和低指纹相似性的药物类化合物,确保组合中的异质性.
- 对蛋白质类的分析证实了数据集的多样性.
- 数据集结构为各种应用,包括对比对齐方法,生成培训/测试集和经验软件评估.
结论:
- LOBSTER数据集提供了一个强大的和版本资源,用于推进小分子叠加领域.
- 它的公共可用性和开源脚本使其在计算药物发现的未来研究中更容易使用和适应.
更多相关视频
相关概念视频
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K


